Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Abbott's Robert Ford: Device Chief Looks Ahead After St. Jude Deal

Executive Summary

In an interview with Medtech Insight at this year's JP Morgan Healthcare Conference, the executive VP of medical devices for Abbott Laboratories discussed the firm's recent mega-acquisition of St. Jude Medical, the opportunity in cardiovascular, value-based business models, cybersecurity, and more.


Related Content

Starts & Stops: Valve Repair And Replacement Tech Continues To Attract R&D Investment
Earnings Winners & Losers: The Large Diversified Firms, ABT, BAX, CAH, JNJ
FDA Recommends Security Patch For St. Jude Wireless Cardiac Devices
Abbott Becomes CRM Player Overnight By Completing St. Jude Deal
J&J Buys Abbott's Ophthalmics Business For $4bn-Plus


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts